Research in animal models shows activity at approximately 0.5mcg/kg, though human protocols typically use standardized doses in the 1-3mg range regardless of body weight
Yeah, you don't need that
in the 100 mg dose present here, serious GI effects are uncommon, but mild nausea or stomach discomfort could occur in sensitive patients
For athletes dealing with tendinopathy -- rotator cuff, patellar, Achilles, elbow -- BPC-157 targets the exact bottleneck that keeps these injuries from resolving: insufficient blood supply and slow collagen turnover in the damaged tissue
Those three human pilots include: a Phase I safety study in healthy volunteers (2003, well-tolerated)
The pathogens identified in PCD are similar to CF but with H